Literature DB >> 21109194

Class IA phosphatidylinositol 3-kinase in pancreatic β cells controls insulin secretion by multiple mechanisms.

Kazuma Kaneko1, Kohjiro Ueki, Noriko Takahashi, Shinji Hashimoto, Masayuki Okamoto, Motoharu Awazawa, Yukiko Okazaki, Mitsuru Ohsugi, Kazunori Inabe, Toshihiro Umehara, Masashi Yoshida, Masafumi Kakei, Tadahiro Kitamura, Ji Luo, Rohit N Kulkarni, C Ronald Kahn, Haruo Kasai, Lewis C Cantley, Takashi Kadowaki.   

Abstract

Type 2 diabetes is characterized by insulin resistance and pancreatic β cell dysfunction, the latter possibly caused by a defect in insulin signaling in β cells. Inhibition of class IA phosphatidylinositol 3-kinase (PI3K), using a mouse model lacking the pik3r1 gene specifically in β cells and the pik3r2 gene systemically (βDKO mouse), results in glucose intolerance and reduced insulin secretion in response to glucose. β cells of βDKO mice had defective exocytosis machinery due to decreased expression of soluble N-ethylmaleimide attachment protein receptor (SNARE) complex proteins and loss of cell-cell synchronization in terms of Ca(2+) influx. These defects were normalized by expression of a constitutively active form of Akt in the islets of βDKO mice, preserving insulin secretion in response to glucose. The class IA PI3K pathway in β cells in vivo is important in the regulation of insulin secretion and may be a therapeutic target for type 2 diabetes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109194      PMCID: PMC3736578          DOI: 10.1016/j.cmet.2010.11.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  51 in total

1.  Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.

Authors:  Kohjiro Ueki; Claudine M Yballe; Saskia M Brachmann; David Vicent; John M Watt; C Ronald Kahn; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells.

Authors:  B Leibiger; I B Leibiger; T Moede; S Kemper; R N Kulkarni; C R Kahn; L M de Vargas; P O Berggren
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion.

Authors:  S Nagamatsu; Y Nakamichi; C Yamamura; S Matsushima; T Watanabe; S Ozawa; H Furukawa; H Ishida
Journal:  Diabetes       Date:  1999-12       Impact factor: 9.461

4.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia.

Authors:  E Bernal-Mizrachi; W Wen; S Stahlhut; C M Welling; M A Permutt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.

Authors:  Kohjiro Ueki; David A Fruman; Saskia M Brachmann; Yu-Hua Tseng; Lewis C Cantley; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

7.  Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha.

Authors:  D A Fruman; F Mauvais-Jarvis; D A Pollard; C M Yballe; D Brazil; R T Bronson; C R Kahn; L C Cantley
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.

Authors:  R N Kulkarni; M Holzenberger; D Q Shih; U Ozcan; M Stoffel; M A Magnuson; C R Kahn
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

9.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

Authors:  N Kubota; K Tobe; Y Terauchi; K Eto; T Yamauchi; R Suzuki; Y Tsubamoto; K Komeda; R Nakano; H Miki; S Satoh; H Sekihara; S Sciacchitano; M Lesniak; S Aizawa; R Nagai; S Kimura; Y Akanuma; S I Taylor; T Kadowaki
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

10.  Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion.

Authors:  Barbara Leibiger; Tilo Moede; Sabine Uhles; Christopher J Barker; Marion Creveaux; Jan Domin; Per-Olof Berggren; Ingo B Leibiger
Journal:  FASEB J       Date:  2010-01-08       Impact factor: 5.191

View more
  45 in total

1.  Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.

Authors:  Ximena Lopez; Aaron Cypess; Raquel Manning; Sheila O'Shea; Rohit N Kulkarni; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.

Authors:  Himadri Singh; Sireesha Ganneru; Venkata Malakapalli; Maniprabha Chalasani; Giridharan Nappanveettil; Ramesh R Bhonde; Vijayalakshmi Venkatesan
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 3.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

4.  Pancreatic β-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription.

Authors:  Emilyn U Alejandro; Gareth E Lim; Arya E Mehran; Xiaoke Hu; Farnaz Taghizadeh; Dmytro Pelipeychenko; Manuela Baccarini; James D Johnson
Journal:  FASEB J       Date:  2011-08-04       Impact factor: 5.191

Review 5.  β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor.

Authors:  Amanda Oakie; Rennian Wang
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

6.  Long-term c-Kit overexpression in beta cells compromises their function in ageing mice.

Authors:  Amanda Oakie; Zhi-Chao Feng; Jinming Li; Jenna Silverstein; Siu-Pok Yee; Rennian Wang
Journal:  Diabetologia       Date:  2019-06-01       Impact factor: 10.122

7.  PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport.

Authors:  Jing Li; Jun Song; Margaret G Cassidy; Piotr Rychahou; Marlene E Starr; Jianyu Liu; Xin Li; Garretson Epperly; Heidi L Weiss; Courtney M Townsend; Tianyan Gao; B Mark Evers
Journal:  Mol Endocrinol       Date:  2012-06-14

8.  Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.

Authors:  Karin Åvall; Yusuf Ali; Ingo B Leibiger; Barbara Leibiger; Tilo Moede; Meike Paschen; Andrea Dicker; Elisabetta Daré; Martin Köhler; Erwin Ilegems; Midhat H Abdulreda; Mark Graham; Rosanne M Crooke; Vanessa S Y Tay; Essam Refai; Stefan K Nilsson; Stefan Jacob; Lars Selander; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

9.  Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes.

Authors:  Marie H Solheim; Jonathon N Winnay; Thiago M Batista; Anders Molven; Pål R Njølstad; C Ronald Kahn
Journal:  Diabetes       Date:  2018-05-03       Impact factor: 9.461

10.  Functional differences between aggregated and dispersed insulin-producing cells.

Authors:  A Chowdhury; O Dyachok; A Tengholm; S Sandler; P Bergsten
Journal:  Diabetologia       Date:  2013-04-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.